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INTRODUCTION
Obesity and lifestyle -related diseases are major problems faced
by people in developed nations. Although exercise training pre-
vents the progression of diabetes and obesity (1), motivation for
exercise is generally low in obese animals and humans. Increasing
motivation for exercise is the best treatment for obesity because
there is a report that education on the importance of exercise train-
ing improves motivation level for exercise (2). Increasing non-
exercise activity thermogenesis (NEAT), a mechanism by which
small amounts of energy is spent has been suggested to prevent
weight gain. NEAT is the predominant component of thermogene-
sis activity, and involves the energy expenditure associated with
all the activities except for sports- like exercise, sleeping, and food
intake (3). Some neuronal peptides and hormones are also involved
in the regulation of locomotion activity as well as food intake and
energy metabolism. Orexin/hypocretin, a neuropeptide locally pro-
duced in lateral hypothalamic area, elevates locomotion activity
and oxygen consumption ; thereby, increasing NEAT, and as a
consequence resisting weight gain (4-7). On the other hand, adi-
pocytokines, secreted from white adipose tissue (WAT), play an
important role in energy homeostasis. Of these molecules, adi-
ponectin, an adipocytokine secreted hormone, has been known to
exhibit anti -diabetic and anti -atherogenic effects (8, 9). Adiponectin,
is secreted exclusively by the WAT and has been shown to in-
crease the sensitivity of peripheral tissues to insulin (10). It has
been suggested that the decreased plasma adiponectin levels in
obesity and type 2 diabetes may relate to insulin resistance (11,
12). Thus, adiponectin and its receptors have been considered as
therapeutic targets of new drug development for metabolic syn-
drome. However, there has been no evidence yet that central adi-
ponectin is involved in locomotion activity and the regulation of
NEAT despite adiponectin receptors being expressed in the hypo-
thalamus.
In this study, we examined whether adiponectin had a role on
home cage activity and/or wheel running activity either in Wister
rats or Spontaneously-Running Tokushima-Shikoku (SPORTS)
rats that we established from an original line of the Wister strain
that had shown high levels of spontaneous wheel running activity
in our laboratory (13). This knowledge may contribute to the es-
tablishment of a new strategy for the prevention of obesity and
lifestyle -related diseases.
MATERIALS AND METHOD
Animals
We used male Wister rats (SLC, Inc, Shizuoka Japan) and
SPORTS rats. At 12 weeks of age, the SPORTS rats have shown
almost six times higher running activity than the control Wister
rats, and have therefore been used in this study (13). All the rats
were housed singly at a constant room temperature of 231
with a 12-h light-dark cycle (lights on at 8 AM), and were fed a
standard nonpurified diet (Oriental Yeast, Tokyo, Japan) with food
and water available ad libitum. This study conformed to the guide-
lines for the care and use of Laboratory animals of the University
of Tokushima Graduate School, Institute of Health Bioscience. All
efforts were made to minimize animal suffering and to reduce
the number of animals used in the experiments. In addition, we
produced destruction model of the mediobasal hypothalamus.
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SPORTS rats received intraperitoneal injection of monosodium glu-
taminate (MSG) (4 mg/weight (g)) until 3 -5 days postnatal. Dose
of MSG was selected as previously described (14).
Intracerebroventricular cannulation and injection
The rats were anesthetized by intraperitoneal injection of sodium
pentobarbital (100 μl/kg body weight), and a stainless-steel guide
cannula was inserted into the lateral ventricle (AP=-1.0 mm, L=
+1.5 mm, H=+3.6 mm taken from bregma). The guide cannula
was fixed in the skull by adhesive and dental acrylic cement. A
stainless-steel dummy cannula was inserted into the guide and
kept there until the start of the experiment. After surgery, the rats
were allowed to recover for at least one week. The SPORTS rats
received the intracerebroventricular injection of vehicle (0.9% sa-
line), 5 μg adiponectin (1 μg/μl) (Enzo Biochem Inc., New York,
America) at 10 PM.
Measurement of locomotion activity and Oxygen consumption
We measured two types of locomotion activity : home cage and
wheel running activity. Home cage activity was measured by ani-
mal movement analysis system (ACTIMO System ; Shintechno,
Fukuoka, Japan). Wheel running activity was measured by Wheel
running cage (Shinano Ltd, Tokyo, Japan). The data was acquired
at 2 h intervals for 48 h. We used Oxymax (Columbus Instruments,
USA) to measure oxygen consumption (VO2). The data was ac-
quired at 12-h intervals for 24 h.
Statistical analysis
Results were expressed as meansSEM. All data were analyzed
by student t - tests and paired t- tests. P0.05 was assumed to in-
dicate statistical significance.
RESULTS
Adiponectin regulates home cage activity via the central nerve
system
Adiponectin provides health benefit by improving insulin resis-
tance by regulating food intake and metabolism (10, 15, 16). In this
study, we hypothesized that adiponectin contributes to systemic
metabolism by regulating exercise. We found that the injection of
adiponectin into the lateral ventricle of the Wister rats decreased
home cage activity (Fig. 1A) while there was no significant differ-
ence in food intake and oxygen consumption (Fig. 1B, C). These
data suggested that adiponectin affects home cage activity without
changing food intake and oxygen consumption.
Adiponectin regulates spontaneous activity.
As expected, SPORTS rats showed high level of wheel running
activity compared with the Wister rats (13). We examined whether
the locomotion activity had any suppressive effect by adiponectin
in the wheel running activity of the SPORTS rats. Injection of adi-
ponectin into lateral ventricle of SPORTS rats decreased home
cage activity during the dark phase compared with that of saline
injection, but wheel running activity did not change compared with
that of saline injection (Fig. 2A, B). Food intake and oxygen con-
sumption did not change after injection of adiponectin compared
with saline (Fig. 2C, D). From these results, we demonstrated that
adiponectin action in the central nervous system suppressed home
cage activity, but did not affect wheel running activity.
MSG treatment canceled exercise-suppressive effect of adiponectin.
We examined the exercise regulation site of adiponectin. In keep-
ing with a previous report that injection of monosodium gluta-
mate (MSG) during the neonatal period destroyed mediobasal
Figure1. Effect of intracerebroventricular injection of adiponectin in a Wister rat
(A) Injection of adiponectin showed suppressive effect of home cage activity in Wister rats (n=4). Values are meanSE * p0.05, * *p0.01
(B) Injection of adiponectin showed no significant difference of food intake in Wister rats (n=4). Values are meanSE (C) Injection of adiponectin
showed no significant difference of oxygen consumption in Wister rats (n=4). Values are meanSE
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hypothalamus causing increased food intake (17), we also used
MSG in our study to destroy the hypothalamus. MSG-treated
SPORTS rats showed a high amount of food intake compared with
MSG non-treated SPORTS rats (MSG treatment 23.851.36 g,
MSG non-treatment 16.011.25 g). Exercise suppressive effect of
adiponectin was canceled in MSG-treated SPORTS rats (Fig. 3A).
Food intake didn’t change even in MSG non-treatment group
(Fig. 3B). These results suggested that the regulation of locomo-
tion activity in home cage is through the mediobasal hypothalamus.
DISCUSSION
Adiponectin has been shown to increase the insulin sensitivity in
peripheral tissues, and it has been suggested that the decreased
plasma adiponectin level in obesity and type 2 diabetes contributed
to insulin resistance. Therefore, adiponectin has been known as an
anti -diabetic adipocytokine (8). In this study, however, we observed
that intracerebroventricular injection of adiponectin in rats decreased
locomotion activity in home cage especially in the active phase with-
out significant change in food intake and oxygen consumption.
This result indicates a possibility that adiponectin has a function to
reduce physical activity and possibly even NEAT via the central
nervous system.
We further determined whether adiponectin suppressed the mo-
tivation of voluntary wheel running exercise in SPORTS rats, which
showed almost two times amount of the home cage activity and six
times amount of the wheel running activity compared with control
Wister rats (13). We observed that injection of adiponectin into the
lateral ventricle in SPORTS rats did not decrease wheel running
activity. However, central adiponectin suppressed home cage ac-
tivity even in SPORTS rats. These results suggest that adiponectin
may regulate home cage activity independent to the pathway of
voluntary exercise although the critical region in the brain for the
motivation of locomotion activity is not clear.
The medial hypothalamus was thought to be the one of the sub-
thalamic locomotor regions in animals (18), while Narita et al. re-
ported that chemical stimulation of ventromedial hypothalamus
(VMH) in rats enhanced running activity (19, 20). Therefore, we
produced a hypothalamus-destruction model rat using MSG to ex-
amine whether adiponectin acts on VMH to enhance locomotion
activity in home cage. Subcutaneous injection of MSG during the
Figure2. Effect of intracerebroventricular injection of adiponectin in a SPORTS rat
(A) Injection of adiponectin showed no significant difference of wheel running activity (n=4). Values are meanSE (B) Injection of adiponectin
showed suppressive effect of home cage activity (n=4). Values are meanSE * p0.05 (C) Injection of adiponectin showed no significant differ-
ence of food intake (n=4). Values are meanSE (D) Injection of adiponectin showed no significant difference of oxygen consumption (n=4). Val-
ues are meanSE
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neonatal period destroys the mediobasal hypothalamus including
VMH (17). The present study showed that suppressive effect of
adiponectin on home cage was canceled by the injection of adi-
ponectin into the lateral ventricle in MSG-treated SPORTS rats.
However, adiponectin receptors are reported to express in the ar-
cuate nucleus, paraventricular nucleus, and the lateral hypothalamic
area in hypothalamus of rodents, while there is no visible evidence
that adiponectin receptors are expressed in VMH. Taken together,
these findings suggest that adiponectin may regulate home cage
indirectly through the mediobasal hypothalamus.
Orexin and hypocretin are synonymous terms, and a typical neu-
ropeptide for the induction of locomotion activity concomitant with
food seeking behavior. There are some controversial reports con-
cerning adiponectin- induced feeding behavior (16, 21, 22). Our ex-
periment showed central adiponectin did not affect food intake,
neither in the Wister nor in the SPORTS rats. Although this dis-
crepancy may be involved in the injected adiponectin concentration,
timing, species, and strains, this consequence indicates that adi-
ponectin action in brain reduces locomotion activity independent
of feeding behavior.
Spontaneous activity is regulated by several hormones or pep-
tides (23, 24). A previous study indicated that intracerebroventricu-
lar injection of leptin increases wheel running activity (25). We also
confirmed that central leptin increased locomotion activity in rats
(data not shown). Intracerebroventricular injection of adiponectin
showed the opposite effect of leptin with respect to exercise. Intrigu-
ingly, leptin also exhibited an opposite action on locomotion activity
depending on food availability (26). Further work is needed to pre-
cisely define the differential role of central adiponectin on locomo-
tion activity depending on the timing of action of energy events in
the whole body.
In conclusion, we showed a novel function of adiponectin on
locomotion-suppressive activity via the mediobasal hypothalamus.
This effect may work independent of other physical activities such
as feeding behavior and voluntary aerobic exercise.
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